30+ Years Medtech Leadership · U.S. & global experience
Navigate What Matters
Independent diligence for private equity, venture capital, startups and strategics—focused on interventional cardiology, interventional radiology, and vascular surgery technologies in CAD, PAD, venous disease, and arterial embolization.
We help you determine which endovascular innovations will translate into procedural adoption, scalable revenue, and profitable returns.
About Us
Independent Expertise. Operator Perspective.
Slocum Advisors is an independent medtech advisory firm founded by Chris Pearson — a 30-year veteran of the medical device industry with direct operating experience building and scaling interventional cardiovascular and vascular businesses across the U.S. and globally. We are not a generalist consulting firm. Our focus is narrow and deep: the devices, procedures, and commercial dynamics of interventional cardiology, interventional radiology, and vascular surgery.
That specialization means we understand the clinical environment, the physician decision-making process, the reimbursement landscape, and the competitive pressures that determine whether a technology achieves meaningful market penetration — or stalls.
Chris Pearson
Founder & Operating Principal
Our Expertise
Where We Focus
Medical Sector Strategies
Our focus is highly specialized: devices used by interventional cardiologists, interventional radiologists, and vascular surgeons, with deep domain expertise in coronary artery disease (CAD) and peripheral arterial disease (PAD), venous disease, and oncology applications—particularly liver-directed therapies.
CAD · PAD · Venous Disease · Oncology
How We Can Help
We help determine whether a technology will move beyond technical promise to consistent procedural adoption, reimbursement durability, and scalable revenue — evaluating clinical differentiation, physician workflow alignment, competitive positioning, and practical barriers to penetration in cath labs, IR suites, and vascular programs.
Expert Strategic Consulting
Leveraging more than three decades of leadership in the medical device sector — with experience in acquisition, divestiture, and building commercial teams delivering profitable growth — we advise on the true investment potential of interventional technologies.
We bring an operator's lens to diligence — identifying not just opportunity, but the friction points that often prevent interventional platforms from achieving meaningful market share.
Chris Pearson, Operating Principal
Executive Leader · Built & Scaled $1.2B Interventional Business · U.S. & Global Strategy Development
Contact
Get In Touch
Given many product, procedure, technologies, workflow, reimbursement and site of care variables at play, we'll help you decide where to play and how to win.